For: | Jun CH, Hong HJ, Chung MW, Park SY, Cho SB, Park CH, Joo YE, Kim HS, Choi SK, Rew JS. Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B. World J Gastroenterol 2013; 19(40): 6834-6841 [PMID: 24187458 DOI: 10.3748/wjg.v19.i40.6834] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i40/6834.htm |
Number | Citing Articles |
1 |
Qing Pang, Jing-Yao Zhang, Xin-Sen Xu, Si-Dong Song, Kai Qu, Wei Chen, Yan-Yan Zhou, Run-Chen Miao, Su-Shun Liu, Ya-Feng Dong, Chang Liu. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence. World Journal of Gastroenterology 2015; 21(18): 5607-5621 doi: 10.3748/wjg.v21.i18.5607
|
2 |
Jindi Zeng, Jiancheng Wu, Shuijiao Pang, Feifei Wang, Xin Yu, Shouhua Zhang, Junquan Zeng, Jinlong Yan, Jianping Lian. Brassicasterol inhibits hepatitis B virus-associated hepatocellular carcinoma development via suppression of AKT signaling pathway. Infectious Agents and Cancer 2023; 18(1) doi: 10.1186/s13027-023-00502-1
|
3 |
Lei Gu, Wen Wen, ZhiXian Wu, Kai Bai, Wei Liu, GuoXiang Lai, DongLiang Li. Abnormal platelet count correlates with poor survival in hepatocellular carcinoma. Infection International 2018; 6(3): 93 doi: 10.1515/ii-2017-0160
|
4 |
Fei Liu, Limei Luo, Zhongjian Liu, Sisi Wu, Wei Zhang, Qin Li, Yufu Peng, Yonggang Wei, Bo Li. A genetic variant in the promoter of CD46 is associated with the risk and prognosis of hepatocellular carcinoma. Molecular Carcinogenesis 2020; 59(11): 1243 doi: 10.1002/mc.23252
|
5 |
Shengkui Tan, Ruoyun Qin, Xiaonian Zhu, Chao Tan, Jiale Song, Linyuan Qin, Liu Liu, Xiong Huang, Anhua Li, Xiaoqiang Qiu. Associations between single-nucleotide polymorphisms of human exonuclease 1 and the risk of hepatocellular carcinoma. Oncotarget 2016; 7(52): 87180 doi: 10.18632/oncotarget.13517
|
6 |
Xiaonian Zhu, Zhigang Wang, Xiaoqiang Qiu, Chao Tan, Hongping Yu, Chunhua Bei, Linyuan Qin, Yuan Ren, Shengkui Tan. Associations between single nucleotide polymorphisms in RYBP and the prognosis of hepatocellular carcinoma in a Chinese population. Carcinogenesis 2017; 38(5): 532 doi: 10.1093/carcin/bgx031
|